{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:17:18Z","timestamp":1773296238812,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.080","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T14:01:17Z","timestamp":1312380077000},"page":"7357-7363","source":"Crossref","is-referenced-by-count":82,"title":["Safety and immunogenicity of a candidate parvovirus B19 vaccine"],"prefix":"10.1016","volume":"29","author":[{"given":"David I.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana M. El.","family":"Sahly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Shelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walla","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"February (6)","key":"10.1016\/j.vaccine.2011.07.080_bib0005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.07.080_bib0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.healun.2010.03.003","article-title":"Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients","volume":"29","author":"Breinholt","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"April (13)","key":"10.1016\/j.vaccine.2011.07.080_bib0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMc0911362","article-title":"Human parvovirus B19-associated myocarditis","volume":"362","author":"Bock","year":"2010","journal-title":"N Engl J Med"},{"issue":"May (8855)","key":"10.1016\/j.vaccine.2011.07.080_bib0020","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0140-6736(93)91145-C","article-title":"Human parvovirus infection in homozygous sickle cell disease","volume":"341","author":"Serjeant","year":"1993","journal-title":"Lancet"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2011.07.080_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1086\/505082","article-title":"Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea","volume":"194","author":"Wildig","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.080_bib0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2334-10-88","article-title":"Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study","volume":"10","author":"Wildig","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.080_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00428-002-0732-8","article-title":"Parvovirus B19: a pathogen responsible for more than hematologic disorders","volume":"442","author":"Bultmann","year":"2003","journal-title":"Virchows Arch"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.07.080_bib0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2796.2006.01697.x","article-title":"Clinical aspects of parvovirus B19 infection","volume":"260","author":"Broliden","year":"2006","journal-title":"J Intern Med"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.07.080_bib0045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S0950268807009661","article-title":"Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection","volume":"136","author":"Mossong","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.07.080_bib0050","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.88.11.4646","article-title":"Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions","volume":"88","author":"Kajigaya","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.07.080_bib0055","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1086\/368382","article-title":"Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1","volume":"187","author":"Ballou","year":"2003","journal-title":"J Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.07.080_bib0060","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/167.5.1034","article-title":"Candidate recombinant vaccine for human B19 parvovirus","volume":"167","author":"Bansal","year":"1993","journal-title":"J Infect Dis"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.07.080_bib0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Resp Viruses"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.07.080_bib0070","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/erv.10.111","article-title":"MF59™ as a vaccine adjuvant: a review of safety and immunogenicity","volume":"9","author":"El Sahly","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.07.080_bib0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcv.2005.12.008","article-title":"Development of an improved method of detection of infectious parvovirus B19","volume":"35","author":"Wong","year":"2006","journal-title":"J Clin Virol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.07.080_bib0080","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.76.4.2014-2018.2002","article-title":"The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity","volume":"76","author":"Dorsch","year":"2002","journal-title":"J Virol"},{"issue":"June (5)","key":"10.1016\/j.vaccine.2011.07.080_bib0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jnr.10239","article-title":"Glutamate signalling and secretory phospholipase A2 modulate the release of arachidonic acid from neuronal membranes","volume":"68","author":"Rodriguez De Turco","year":"2002","journal-title":"J Neurosci Res"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.07.080_bib0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0091-6749(95)70059-5","article-title":"Type I skin reactivity to native and recombinant phospholipase A2 from honeybee venom is similar","volume":"96","author":"Muller","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.07.080_bib0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0091-6749(98)70179-4","article-title":"Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli","volume":"101","author":"Soldatova","year":"1998","journal-title":"J Allergy Clin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:01:46Z","timestamp":1592784106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":19,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11011303"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}